Investors & Media

SEC Filing Details

Investor Relations Menu
Financials & Filings
Investor Contact

Adam Levy
Senior Vice President,
Investor Relations
alevy@zentalis.com

Emily White
Solebury Strategic Communications
ewhite@soleburystrat.com

Media Contact

Julia Deutsch
Solebury Strategic Communications
jdeutsch@soleburystrat.com

Document Details

Form
Filing Date
Apr 13, 2022
Document Date
Apr 11, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.
Filer
BUNKER KEVIN D.